It is unclear whether the same mechanism applies to mitochondrial PEPCK (PEPCK-M/ Pck2), but 3-MPA treatment of lung cancer cell lines induced similar responses to that of PEPCK-M gene specific knock-down6. This evidence concerns the gene PCK2 and lung carcinoma.